You are invited to a Treatment-Resistant Schizophrenia Promotional Webinar

Viatris is delighted to invite you to our upcoming TRS webinar featuring Professor Ramalingam Chithiramohan, Consultant Psychiatrist, Birmingham and Solihull Mental Health Foundation Trust. The presentation will focus on a treatment-resistant schizophrenia masterclass.

A speaker Q&A session will follow the presentation and a “Certificate of Attendance” will be available after the webinar.

Speaker

Professor Ramalingam Chithiramohan

Consultant Psychiatrist, Birmingham and Solihull NHS Foundation Trust

Agenda

12.15 onwards

Webinar platform opens for registered delegates

12.30
12.35

Welcome and introduction

Umran Mohammed, Therapy Development Manager, Viatris Mental Health UK

12.35
13.30

Treatment-resistant schizophrenia: a masterclass for healthcare professionals

Professor Ramalingam Chithiramohan

13.30
13.45

Q&A Session

Professor Ramalingam Chithiramohan

13.45

Webinar closes

Prescribing Information

Clozaril®/Clozapine Mylan is indicated in treatment-resistant schizophrenic patients and in schizophrenia patients who have severe, untreatable neurological adverse reactions to other antipsychotic agents, including atypical antipsychotics. Treatment resistance is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two different antipsychotic agents, including an atypical antipsychotic agent, prescribed for adequate duration.

Welcome to the Viatris Connect portal for UK healthcare professionals (HCPs) where you’ll find promotional and non-promotional information about Viatris’ portfolio, therapy area materials and professional resources.

I am a UK healthcare professional